Assessment of the specificity and potency of chemical and antibody inhibitors of specific isoforms of cytochrome P450

被引：0
|
作者：
Glazier, Anthony P.
Wilkinson, David J.
Bettany, Louise
Weir, Caroline S.
Lankester, David J.
机构：
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
45
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [31] Cytochrome P450 and chemical toxicology.
    Guengerich, F. Peter
    CHEMICAL RESEARCH IN TOXICOLOGY, 2006, 19 (12) : 1679 - 1679
  • [32] OMEPRAZOLE, CYTOCHROME P450, AND CHEMICAL CARCINOGENESIS
    LUCIER, GW
    THOMPSON, CL
    HOEL, DG
    GASTROENTEROLOGY, 1992, 102 (05) : 1823 - 1824
  • [33] Cytochrome P450 networks in chemical space
    Soyoung Lee
    Dongsup Kim
    Archives of Pharmacal Research, 2010, 33 : 1361 - 1374
  • [34] Cytochrome P450 Networks in Chemical Space
    Lee, Soyoung
    Kim, Dongsup
    ARCHIVES OF PHARMACAL RESEARCH, 2010, 33 (09) : 1361 - 1374
  • [35] Effect of ademetionine on cytochrome P450 isoforms activity in rats
    Tong, Shuhua
    Guo, Jiayi
    Song, Huanchun
    Lv, Shiwen
    Zhu, Yalan
    Ma, Jianshe
    Zheng, Yuancai
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (06): : 9716 - 9722
  • [36] Effect of Aconitine on Three Cytochrome P450 Isoforms in Rats
    Hu, Ming-lei
    Zheng, Shuang-li
    Ye, Qiang
    LATIN AMERICAN JOURNAL OF PHARMACY, 2014, 33 (01): : 65 - 70
  • [37] Significance of the Minor Cytochrome P450 3A Isoforms
    Ann K. Daly
    Clinical Pharmacokinetics, 2006, 45 : 13 - 31
  • [38] Regulation of cytochrome P450 isoforms by histamine in rat liver
    Dávila, VM
    Belmont, JA
    Albores, A
    Montero, RD
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2004, 44 (03) : 194 - 194
  • [39] Inhibition of human cytochrome P450 isoforms in vitro by zafirlukast
    Shader, RI
    Granda, BW
    von Moltke, LL
    Giancarlo, GM
    Greenblatt, DJ
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1999, 20 (08) : 385 - 388
  • [40] Significance of the minor cytochrome P450 3A isoforms
    Daly, AK
    CLINICAL PHARMACOKINETICS, 2006, 45 (01) : 13 - 31
12345